Prevalence of obesity in a Canarian community.: Association with type 2 diabetes mellitus:: the Guia Study

被引:17
作者
de Pablos-Velasco, PL
Martínez-Martín, FJ
Rodríguez-Pérez, F
机构
[1] Hosp Dr Negrin, Dept Endocrinol, Las Palmas Gran Canaria 350120, Spain
[2] Hosp Dr Negrin, Dept Prevent Med, Las Palmas Gran Canaria, Spain
关键词
obesity; central obesity; type 2 diabetes mellitus; cardiovascular risk factors;
D O I
10.1038/sj.ejcn.1601401
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: We sought to estimate the prevalence of obesity and central obesity, and their association with type 2 diabetes mellitus in the Canarian community of Guia. Design and setting: Population-based study. Subjects: A random sample of 691 subjects over 30 y old (stratified by age and sex) was studied. Data and measures: Age, sex, family history of diabetes and medication use were obtained, height, weight and waist circumference were measured and standard oral glucose tolerance tests were performed Results: The prevalences of obesity/central obesity were 36.5%/66.5% (women) and 23.6%/32.0% (men). The prevalence of diabetes was 21.0% (women) and 18.4% (men). These rank among the highest in Europe. Bivariate analyses show a strong association of both obesity and central obesity with diabetes mellitus (P<0.001), but in a multivariate model, waist circumference (P<0.001) but not body mass index (P=0.212) was retained as an independent predictor of diabetes. Conclusion: The prevalences of obesity, central obesity and diabetes in our community are extremely high, and central obesity is a better predictor of diabetes than obesity.
引用
收藏
页码:557 / 560
页数:4
相关论文
共 21 条
[1]   Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver [J].
Abel, ED ;
Peroni, O ;
Kim, JK ;
Kim, YB ;
Boss, O ;
Hadro, E ;
Minnemann, T ;
Shulman, GI ;
Kahn, BB .
NATURE, 2001, 409 (6821) :729-733
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]   ABDOMINAL OBESITY AND THE METABOLIC SYNDROME [J].
BJORNTORP, P .
ANNALS OF MEDICINE, 1992, 24 (06) :465-468
[5]   Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].
Boden, G .
DIABETES, 1997, 46 (01) :3-10
[6]   Visceral adiposity and risk of type 2 diabetes - A prospective study among Japanese Americans [J].
Boyko, EJ ;
Fujimoto, WY ;
Leonetti, DL ;
Newell-Morris, L .
DIABETES CARE, 2000, 23 (04) :465-471
[7]   Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population -: comparison of the 1997 ADA and the 1985 WHO criteria.: The Guia Study. [J].
de Pablos-Velasco, PL ;
Martínez-Martín, FJ ;
Rodríguez-Pérez, F ;
Anía, J ;
Losada, A ;
Betancor, P .
DIABETIC MEDICINE, 2001, 18 (03) :235-241
[8]   Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats [J].
Dobbins, RL ;
Szczepaniak, LS ;
Bentley, B ;
Esser, V ;
Myhill, J ;
McGarry, JD .
DIABETES, 2001, 50 (01) :123-130
[9]   The role of TNFα and TNF receptors in obesity and insulin resistance [J].
Hotamisligil, GS .
JOURNAL OF INTERNAL MEDICINE, 1999, 245 (06) :621-625
[10]   EFFECT OF PAST AND CONCURRENT BODY-MASS INDEX ON PREVALENCE OF GLUCOSE-INTOLERANCE AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES AND ON INSULIN-RESPONSE - THE ISRAEL STUDY OF GLUCOSE-INTOLERANCE, OBESITY AND HYPERTENSION [J].
MODAN, M ;
KARASIK, A ;
HALKIN, H ;
FUCHS, Z ;
LUSKY, A ;
SHITRIT, A ;
MODAN, B .
DIABETOLOGIA, 1986, 29 (02) :82-89